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The alphavirus Sindbis virus (SINV) serves as a model for studying the mechanisms of viral 
encephalomyelitis. Severity of SINV diseases is determined by multiple factors including the host 
immune response and virus strain. Neuroadapted Sindbis virus (NSV) causes severe 
encephalomyelitis with prominent hindlimb paralysis. Toll-like receptors (TLRs) are major regulators 
of antiviral responses, but may also trigger innate immunity-mediated damage to neurons. Endosomal 
TLR stimulation by pathogen/ damage-associated molecular patterns (PAMPs or DAMPs) such as 
misregulated microRNAs can directly cause neuronal cell death. Previous microarray analysis has 
identified two upregulated miRNAs during SINV infection in mice. As a result, the first goal of this 
study was to evaluate the regulation of endosomal TLRs, associated adaptors and the two deregulated 
miRNAs in SINV-infected mice. We also explored the hypothesis that necroptosis, a newly described 
regulated necrosis pathway, contributes to motor neuron degeneration within the spinal cord 
following infection with NSV strain of SINV. This proinflammatory mode of cell death could 
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Sindbis virus induced encephalomyelitis 
Alphaviruses are a group of mosquito-borne, enveloped single-stranded, positive-sense RNA 
viruses that belong to the Togaviridae family. Encephalitic alphaviruses including Western, 
Eastern and Venezuelan equine encephalitis viruses (WEEV, EEEV and VEEV respectively) 
are New World alphaviruses endemic in the Americas [1]. Typical symptoms of New World 
alphavirus infections start with febrile illness, followed by evidence of acute neuroinvasive 
disease such as convulsion, coma, sensory deficits, muscle weakness, and even death [1, 2]. 
EEEV encephalitis, although transmitted to humans at a low rate in the United States, is the 
most lethal arboviral disease and has a case-fatality rate of 33% [3]. Patients that survive 
alphaviral encephalitis may also suffer from long-term neurological sequelae including 
cognitive, emotional, sensory and motor impairment [1, 2]. In contrast, Sindbis virus (SINV) 
and other Old World alphaviruses including Chikungunya virus (CHIKV), Ross River virus 
(RRV) and Semliki Forest virus (SFV) cause fever, malaise, rash and polyarthritis in humans 
and were mainly prevalent in Africa, East Asia and Europe [4], but one emerging and 
spreading worldwide Old World alphavirus has also been reported to affect the nervous 
system. Sporadic cases of CHIKV-induced neurologic diseases have been reported. For 
instance, in a CHIKV outbreak in western India, 16% of the patients showed encephalitis, 
myelopathy, or peripheral neuropathy [5, 6]. Currently, there are no specific antiviral 
therapeutics for alphaviruses; treatment is limited to supportive care. Several CHIKV human 
vaccine candidates are under development, but vaccines for the encephalitic alphaviruses 
have been licensed in horses but not for human use [2]. Therefore, understanding the 
pathogenesis of alphavirus-induced encephalomyelitis is critical for developing effective 
treatments and controls for neuroinvasive alphaviral diseases. 
Although the prototype alphavirus SINV causes arthritis in humans, it shows neurotropism in 
mice and provides a useful model for studying the acute and chronic neuropathology of 
closely related encephalitic alphaviruses. SINV genome RNAs form nucleocapsid complexes 
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with capsid proteins (CPs), and are enveloped by host-derived lipid bilayers that contain 80 
glycoprotein E1/ E2 trimers (Figure 1A) [7, 8]. Envelope proteins E1/ E2 mediate virus 
binding and entry into host cells [9, 10]. Low pH triggers fusion of the virus envelope with 
the endosome membrane and release of the viral genome. Non-structural proteins nsP1- nsP4 
are translated from the 5’ end of the positive-strand RNA genome in the cytoplasm (Figure 
1B). In the late phase of infection, subgenomic mRNAs are transcribed from the 3’ terminal 
structural region [8]. The polyprotein CP-pE2-6K-E1 or CP-pE2-TF is translated from the 
subgenomic RNAs is further processed into structural proteins CP, E1, E2 and two small 
membrane proteins 6K and TF [7].  
Figure 1. Alphavirus virion (A) and genome structure (B) and construction of the TE and NSV 
strains of Sindbis virus (C) [8, 11]. 
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In mice, after intranasal or intracerebral inoculation SINV primarily infects and replicates in 
neurons of the central nervous system (CNS). SINV infections vary in disease severity, 
depending on the virus strain, the maturity of neurons and the genetic background of hosts 
[7]. The two strains of SINV used in this study, neuroadapted Sindbis virus (NSV) and TE, 
are both derived from the original low passage AR339 strain isolated from mosquitos in 1952. 
NSV was produced by serial passage in mice brains. The TE strain was constructed by 
recombination of Toto1101 cDNA clone of SINV with the NSV E2 glycoprotein fragment 
and the original AR339 E1 sequence (Figure 1C) [11]. Mutations of critical amino acids in 
SINV envelope proteins E1/E2, TF, nsP3 or the 5’ nontranslated region are able to alter the 
neurovirulence of SINV [7]. AR339 and TE strains cause only mild disease in adult C57BL/6 
mice, while the fatal NSV strain causes more than 90% mortality. Mice infected with NSV 
show signs of flaccid hindlimb paralysis 4 days post infection (dpi) and succumb within 7 to 
10 dpi [12]. Newborn mice infected with TE also have shorter average survival time than 
those inoculated with AR339 [13]. The enhanced virulence of NSV and TE is partly due to 
the Histidine-55 substitution for Glutamine in glycoprotein E2 [14]. Additional mutations that 
appear in the NSV strain during neuroadaptation are associated with increased replication 
efficiency, more intense inflammatory response and neuronal damage in the brain and spinal 
cord. [7]  
AR339 and TE strains cause nonfatal encephalitis in adult mice, while infection of younger 
weanling or newborn mice leads to fatal encephalomyelitis. The age- dependent decrease in 
SINV susceptibility is primarily due to the intrinsic resistance of mature neurons rather than 
the development of the immune system [7]. Previous work in our lab has shown that neuronal 
maturity is associated with increased baseline mRNA levels of interferon regulatory factor 
(IRF)-3, IRF7, interferon (IFN)-β and several IFN-stimulated genes (ISGs) [15]. 
Undifferentiated neurons also express a dominant negative γ isoform of IRF7, which switches 
to the full-length active isoform in mature neurons. More rapid activation of IFN and ISGs in 
mature neurons thus restricts virus replication and SINV-induced neuronal apoptosis [15]. 
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These findings also emphasized the importance of innate immune signaling in controlling 
SINV infection.  
Toll-like receptor signaling during neurotropic virus infection 
Several families of viruses, including alphaviruses, flaviviruses (eg. West Nile (WNV), 
Japanese encephalitis (JEV), St Louis encephalitis (SLEV) and tick-borne encephalitis), 
enteroviruses (eg. Enterovirus 71, poliovirus), rhabdoviruses (eg. rabies, vesicular stomatitis 
virus (VSV)), bunyavirus (eg. La Crosse (LACV)) and herpesviruses (eg. herpes simplex 
(HSV)) may invade and cause irreversible damage in the terminally differentiated neurons of 
the CNS [16]. As neurons are nonrenewable, the CNS must be protected from viral infections 
by tightly regulated immune responses [16, 17]. The innate immune response to neurotropic 
virus infection is important for the initial pathogen recognition, effective restriction of virus 
propagation and induction of proinflammatory genes. Detection of conserved pathogen 
associated molecular patterns (PAMPs) is mediated by four groups of pathogen recognition 
receptors (PRRs): Toll-like receptors (TLRs), RIG-I like receptors (RLRs), NOD-like 
receptors (NLRs), and cytosolic DNA sensors. PRR activation pathways converge on the 
activation of transcription factors including IRF3, IRF7 and NFκB, and induction of 
proinflammatory genes (Figure 2) [17, 18].  
Surface or endosomal membrane bound TLRs are capable of recognizing a wide range of 
PAMPs via their N-terminal leucine-rich repeats. Viral nucleic acids are the dominant 
PAMPs of viruses and can be detected by the endosomal TLRs: TLR3 detects double-
stranded RNA, TLR7/ TLR8 recognizes single-stranded RNA, unmethylated DNA activates 
TLR9 and mouse TLR13 is reported to bind bacterial ribosomal RNAs [19]. Upon TLR 
engagement, the cytoplasmic Toll/ IL-1R homology (TIR) domain mediates recruitment of 
TIR-containing adaptor proteins. All TLRs require the prototype TIR family adaptor MyD88 
(myeloid differentiation primary response 88) for signal transduction, except for TLR3 that 
utilizes the adaptor TRIF (TIR domain containing adaptor inducing IFN-β). TIR family 
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adaptors activate IκB kinase-β (Iκκ-β) and TANK binding kinase 1, which then induce 
activation of mitogen-activated protein kinases (MAPKs), NFκB and IRFs. These lead to the 
production of type I IFNs, proinflammatory cytokines, chemokines and other antiviral genes 
[17-19]. TLR signaling provides protection against multiple neurotropic viruses including 
WNV, JEV, poliovirus, VSV and HSV in mice, mainly by stimulation of IFN expression and 
control of virus replication [17, 18].  
 
 
Figure 2. Innate immune responses to virus infection in the central nervous system [18]. Detection 
of viruses in the CNS can be mediated by one of four types of PRRs: TLRs, RLRs, cytosolic DNA 
sensors or NLRs. TLR engagement activates MyD88 or TRIF-dependent signaling pathways that drive 
nuclear translocation of IRF3, IRF7 and nuclear factor (NF)-κB and induce expression of type I IFNs 
and proinflammatory cytokines (such as pro-IL-1β and pro-IL-18). RLRs include retinoic acid-
inducible gene I product (RIG-I), melanoma differentiation-associated antigen 5 (MDA5), and 
laboratory of genetics and physiology 2 (LGP2) that recognize double-strand RNA with blunt ends. 
Activated RIG-I and MDA5 interact with mitochondrial antiviral signaling protein (MAVS), which 
also activate the transcription factors IRF3, IRF7 and NFκB. LGP2, however, serves as a negative 
regulator of RLR pathways. DNA from viruses such as HSV may binds and activates the cytosolic 
DNA sensor cGAS (cyclic GMP-AMP synthase), which catalyzes the synthesis of cyclic guanosine 
monophosphate-adenosine monophosphate (cGAMP). This second messenger and another DNA sensor 
Interferon gamma-inducible protein 16 (IFI16) can activate stimulator of interferon genes (STING) and 
mediate downstream proinflammatory responses. Finally, viral nucleic acids or infection-induced 
cellular stress can activate the cytosolic NLR inflammasomes. For instance, NOD-like receptor family 
pyrin domain-containing 3 (NLRP3) activation and oligomerization lead to the activation of caspase-1, 
which subsequently convert pro-IL-1β and pro-IL-18 to their mature forms. SARM1, a newly 
discovered TIR domain containing protein, can either mediate cytokines and chemokines secretion via 
currently unknown pathways or trigger cell death in response to certain viruses. 
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Recent studies show that TLR activation may also contribute to viral disease pathogenesis. 
For instance, the rhabdovirus rabies virus infection causes fatal encephalitis in wild-type 
mice, while TLR3 deficient mice have lower viral load and higher survival rate [18]. TLR- 
associated neuropathology can also be mediated by SARM1 (Sterile alpha and TIR motif-
containing protein1), the fifth member of TIR family adaptors, which also include the well-
studied MyD88, MYD88-adaptor-like protein (MAL), TRIF and TRIF-related adaptor 
molecule (TRAM) [18-20]. SARM1 is evolutionarily conserved and mammalian SARM1 is 
predominantly expressed in the CNS, and mainly in neurons rather than glial cells. Unlike 
other TIR family members, SARM1 was first identified as a negative regulator of TRIF-
dependent TLR signaling [20]. Though the functions of SARM1 remain to be elucidated, it 
has been shown lately that SARM1 also regulates axon degeneration in mouse, 
Caenorhabditis elegans and Drosophila. Furthermore, SARM1 correlates with neuronal death 
under the stress of oxygen and glucose deprivation, mitochondria destruction, or viral 
infections [18-22]. In the C. elegans model of amyotrophic lateral sclerosis, activation of tir-
1, the SARM1 ortholog, and its downstream signaling pathway are implicated in non-
apoptotic motor neuron degeneration, suggesting SARM1 may play a conserved role in 
neurodegeneration [23].  How these processes occur has yet to be understood. One study 
shows that TLR7/ TLR9 stimulation with agonists induces SARM1 upregulation and 
aggregation in the mitochondria and triggers apoptosis of primary cortical neurons, 
suggesting that SARM1 signaling may contribute to viral pathogenesis in the CNS [24]. In 
addition, Mukherjee et al. reported that MAVS activation upon LACV infection stimulates 
SARM1-dependent mitochondrial damage and neuronal apoptosis in vivo [25]. Apart from 
mediating neuronal death directly, SARM1 signaling also contributes to cytokine production 
and immune-mediated neurodegeneration in the brain during VSV infection [26].  
Identification of microRNAs (miRNAs) as unconventional TLR ligands also elucidated a 
novel TLR-dependent neuropathogenic pathway. MiRNAs are small non-encoding RNAs of 
about 22 nucleotides and are capable of regulating gene transcription and translation. Recent 
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studies suggest that some miRNAs structurally mimic viral RNA, directly bind and activate 
TLR signaling cascades in neighboring cells [27, 28]. It has been hypothesized that 
expression disturbance of specific miRNAs are associated with neurotoxicity during the 
course of virus infections and neurodegenerative diseases [29]. For instance, miR-21 is 
upregulated in macrophage-secreted vesicles (EVs) in HIV/ SIV (human or simian 
immunodeficiency virus) infected brains [30, 31]. Although the trafficking mechanism is not 
well understood, miR-21 contained in EVs activates the endosomal TLR7 pathway and 
induces neuron cell death, which can be inhibited by a necroptosis inhibitor, necrostatin-1 
[30]. Additionally, TLR7 activation by let-7b, a miRNA upregulated in the cerebrospinal 
fluid of patients with Alzheimer's disease, also induces neurodegeneration in mouse models 
[32]. Therefore, we are interested in the involvement of endosomal TLR signaling pathways 
during SINV infections, which can be either protective or pathogenic in the CNS.  
Differential upregulation of endosomal TLRs in the brain by several alphaviruses, including 
VEEV, neurovirulent CHIKV E1: A226V and SFV, has been reported [33-35]. Regulation of 
these TLRs and associated TIR adaptors during SINV infections has not been studied. 
Especially, we would like to know whether SINV induces SARM1 and/ or miRNA 
dysregulation, which may contribute to immune-mediated pathogenesis. Keeping these in 
view, the present study has compared the expression of endosomal TLRs and SARM1 during 
infections with fatal and nonfatal strains of SINV. Based on microarray analysis performed by 
Dr. Yoshinari Ando, miR-21a and miR-146a are induced more than 2 fold by TE infection at 
5 dpi. We want to confirm the results and examine the expression patterns of these two 
miRNAs, using semi-quantitative real-time polymerase chain reactions. 
	 8	
Sindbis virus induced neuronal cell death 
Apoptosis is the first recognized programmed cell death (PCD) pathway and is a crucial 
mechanism for homeostasis and development in multicellular organisms. Characteristic 
morphology changes in apoptotic cells include cytoplasmic shrinkage, nuclear condensation, 
DNA fragmentation, plasma membrane blebbing and formation of apoptotic bodies. These 
hallmarks can be distinguished from necrosis, which occurs with increased cell volume, 
organelle swelling, cell rupture and release of cellular content [36].  
Apoptosis is a tightly controlled process and can be triggered by either extrinsic stimuli of 
death receptors or intrinsic cellular stress. Death receptors, for instance, TNFR and FAS 
receptor ligation induces assembly of intracellular DISC (death inducing signaling complex), 
which then recruits adaptor proteins such as FAS-associated death domain (FADD) via death 
domains and directly cleaves pro-caspase-8 into active caspase-8 [37]. Intrinsic stresses such 
as DNA damage, oxidative stress and excessive Ca2+ influx induce sequestration of anti-
apoptotic B-cell lymphoma 2 (BCL-2) by BH3-only proteins, which allows pro-apoptotic 
BAX or BAK translocation to mitochondria and formation of mitochondrial membrane 
permeability pores. Multiple pro-apoptotic proteins including cytochrome c, apoptosis 
inducing factor (AIF) and endonuclease G then release into cytoplasm from mitochondria. 
Cytochrome c induces “apoptosome” formation by recruiting apoptosis protease activating 
factor-1 (APAF-1) and activates caspase-9 [37]. Executioner caspase-3 and caspase-7 are 
subsequently activated by caspase-8 or -9 and induce apoptotic cell death by proteolysis of 
specific cellular targets such as transcription factors, kinases and Poly (ADP-ribose) 
polymerase 1 (PARP1). Chromosomal DNA fragmentation, one of the apoptotic hallmarks, is 
mediated by endonucleases [37]. 
SINV infection induced apoptosis in vitro occurs in multiple immortalized cell lines (such as 
BHK-21 cells, NSC-34 cells and N18 neuroblastoma) and cultured primary cortical neurons 
[38-40]. SINV- induced apoptosis is initiated during virus entry and acid-driven fusion with 
the cell membrane [38]. This apoptotic cell death is associated with caspase-3 activation and 
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PARP-1 cleavage and can be inhibited by the pancaspase inhibitor zVAD-FMK (N-
benzyloxycarbonyl-Val-Ala-Asp-fluoromethyl ketone) and anti-apoptotic proteins (such as 
Bcl-2, Beclin-1) overexpression [38, 41].  
The ability to induce apoptotic neuron death in the brain and spinal cord of newborn mice 
correlates with the neurovirulence of SINV. In adult mice, however, spinal cord motor neuron 
death appears to employ a non-apoptotic mechanism [12, 40, 42]. Intracerebral inoculation 
with NSV strain leads to neuronal cell death mainly in the hippocampal and lumbar spinal 
cord regions and results in acute flaccid paralysis as well as lethality. Both apoptotic cells that 
are positive for activated caspase-3 and TUNEL (Terminal deoxynucleotidyl transferase 
dUTP nick end labeling) and necrotic cells that are sometimes adjacent to the apoptotic 
neurons can be observed in the brains of infected mice. In contrast, motor neuron 
degeneration in the anterior horns of spinal cord is mainly necrotic, with an absence of 
caspase-3 activation, enlarged nuclei, swollen organelles and loss of membrane integrity [12]. 
Additionally, overexpression of BCL-2 family proteins, BCL-2 and BAX, inhibits 
hippocampal neuronal death and fatal disease in NSV-infected adult mice, but cannot prevent 
lumbar motor neuron destruction or the onset of hindlimb paralysis [43]. Recent studies in our 
lab also demonstrated that TE infection could also induce necrosis of spinal cord motor 
neurons in IRF7-/- mice, which parallels the onset of hindlimb paralysis by 5 dpi. The ratio of 
cleaved caspase-3 to TUNEL positive cells in the spinal cord was lower than that observed in 
the brain, suggesting that caspase-3-independent cell death occurred in the spinal cord of 
IRF7-/- mice. Therefore, it is believed that SINV infection can activate divergent cell death 
pathways in different types of neurons. Necrotic motor neuron death occurs not only in 
alphaviral encephalomyelitis, but also in other motor neuron diseases that may include other 
infectious acute flaccid myelitis and motor neurodegenerative diseases such as ALS. 
Therefore, understanding its mechanism is of interest to us. 
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Regulated necrosis: necroptosis  
PCD used to be a synonym of apoptosis, whereas necrosis was considered to be a form of 
accidental cell death in response to irreversible physicochemical injury. However, 
accumulating genetic, biochemical and physiological evidence unmasked multiple neglected 
non-apoptotic PCD mechanisms and redefined the dichotomy of cell death into three 
categories: apoptosis, autophagic cell death and necrosis [36, 44-46]. The discovery of 
specific genetic programs and chemical inhibitors also revealed the existence of regulated 
necrosis, which is tightly regulated like other PCDs. Several modes of regulated necrosis, 
including necroptosis, pyroptosis, parthanatos, MPT-RN (mitochondrial permeability 
transition- mediated regulated necrosis), ferroptosis/ oxytosis and NETosis (neutrophil 
extracellular trap release-associated cell death), have been proposed based on their unique 
underlying signaling pathways (Figure 3), though they share similar morphological features 
of necrotic cells [36, 44-46].   
Necroptosis is the prototype and best characterized regulated necrosis pathway, and the 
earliest evidence for this pathway was observed in tumor cells that undergo tumor necrosis 
factor-α (TNFα)-induced, caspase-antagonized cell death. The identification of RIP1 and 
RIP3 (receptor-interacting serine/threonine-protein kinase 1 and 3) as crucial regulators of 
TNFα induced necrosis, and the specific inhibitory effect of a RIP1 inhibitor necrostatin-1 
further provided evidence that necroptosis was a programmed necrosis pathway. A variety of 
intracellular and extracellular triggers, for instance, TNFα family receptor ligands, PAMPs, 
DNA damage, T-cell receptor ligation and IFNs, have been reported. Under apoptosis 
deficient conditions, such as FADD knockout or caspase-8 inhibition, these signals initiate the 
formation of a ‘necrosome’ containing RIP1, RIP3 and the downstream substrate MLKL 




Figure 3. Regulated cell death pathways [45]. Apoptosis is the classical caspase-3 mediated PCD, 
induced by either extrinsic death receptor stimuli or intrinsic mitochondrial stress. Apoptotic cells 
progressively dissemble with relatively persistent membrane integrity and limited PAMPs release, and 
are generally considered non-immunogenic. Regulated necrosis (RN) pathways include caspase-
dependent pyroptosis and caspase-independent necroptosis, MPT-RN, parthanatos, ferroptosis/ 
oxytosis and NETosis. Pyroptosis depends on inflammasome formation that activates pro-caspase-1 
and -11. Cleaved caspases then induce osmotic swelling of the cells and release of proinflammatory IL-
1β and IL-18. Necroptosis is the prototype form of caspase-independent regulated necrotic cell death. 
This pathway can be induced by signaling from death receptors, PRRs and IFNs and is mediated by 
sequential activation of RIP3 and MLKL. The term MPT-RN describes the form of regulated necrosis 
associated with cyclophilin D (CYPD) mediated mitochondrial outer membrane permeabilization 
(MOMP). Parthanatos involves hyperactivation of PARP1 and accumulation of PARylated target 
proteins. NAD+ consumed by massive PARylation reactions and AIF (induces apoptosis-inducing 
factor) release triggered by PAR polymers lead to energy crises and necrotic cell death.  Ferroptosis 
and oxytosis are two overlapping cell death-modalities that occur when the system XC− Cys/Glu 
antiporters are inhibited. Reduced levels of intracellular L-Cys results in glutathione (GSH) depletion 
and consequently GSH peroxidase 4 (GPX4) inhibition and lipid peroxidation. Ferroptosis is associated 
with iron-dependent reactive oxygen species (ROS) generation, lipid peroxidation and lysosomal 
membrane permeabilization (LMP). Glutamate excitotoxicity induced neuronal necrosis is typically 
classified as oxytosis, and it depends on calcium-dependent calpain activation rather than iron 
metabolism. NETosis, as its name suggests, requires the release of NET (neutrophil extracellular trap) 
that contains neutrophil chromatin, histone and other intracellular proteins. Unlike apoptosis, regulated 
necrosis pathways are characterized by cell rupture, the release of PAMPs and proinflammatory 





Extensively studied TNFα induced cell death exemplifies the crosstalk between apoptosis and 
necroptosis (Figure 4) [46]. TNFR1 trimerization induces pro-inflammatory responses by 
forming complex I comprising TNFR1-associated death domain protein (TRADD), 
ubiquitinated RIP1 and other components and activating NFκB/ MAPK pathway. In 
sensitized cells, deubiquitination of RIP1 by deubiquitinating enzyme cylindromatosis 
(CYLD) destabilizes complex I, and initiates the association of FADD, pro-caspase 8 and 
FLICE­ like inhibitory protein long isoform (FLIPL). Formation of TRADD- dependent 
complex IIa or RIP1- dependent complex IIb allows caspase-8 dependent apoptosis. FLIPL 
and pro-caspase-8 heterodimer also serves as a brake of necrosome or complex IIc assembly 
by proteolysis of CYLD, RIP1 and RIP3. When caspase-8 is inhibited by viral encoded 
inhibitors (such as CrmA and vIRA) or synthetic inhibitors (such as zVAD-FMK) and RIP3 
and MLKL are expressed at sufficiently high levels, TNFα tends to induce necroptosis. 
RIPK1 and RIPK3 associate via their RHIM (RIP homotypic interaction motif) domains; 
trans- and auto-phosphorylated RIP1 and RIP3 then associate in an amyloid- like necrosome, 
recruit and phosphorylate the downstream executor MLKL. Activated MLKLs trimerize 
through exposed amino-terminal coiled-coil domain and translocate to the plasma membrane, 
possibly leading to ion influx-dependent necroptotic death [36, 44-46]. 
Apart from death receptors, PAMPs can also induce necroptosis through PRRs. With the 
presence of caspase inhibitor zVAD-FMK, stimulation of TLR3 by poly(I:C) or TLR4 by 
lipopolysaccharide (LPS) will recruit RIP3 through the RHIM-containing adaptor protein 
TRIF and induce either RIP1-dependent or independent necroptosis [36]. Another RHIM 
domain-containing protein, DAI (DNA-dependent activator of IFN regulatory factors), also 
recognizes viral double strand DNA and leads to RIP3- dependent necrosome formation 
during MCMV infection [47]. Recent studies also found that cytosolic RIG-I and STING 
pathway activation (by Sendai virus and MHV68, respectively) can mediate necroptosis in 
L929 cells [48]. 
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Figure 4. TNFα  induced apoptosis and necroptosis pathway [47]. 
Necroptosis is generally considered a more potent inflammation inducer than apoptosis, 
owing to the more acute and massive release of damage associated molecular patterns 
(DAMPs) from necrotic cells (Figure 3) [36, 45]. Although no necroptosis- specific DAMPs 
have been discovered so far, DAMPs such as HMGB1 (high-mobility group box 1), IL-1 
family cytokines, S100 proteins a9 and mitochondrial DNA (mtDNA) were found to be 
upregulated in necroptotic tissues. These DAMPs may then provoke and amplify 
inflammatory responses, and possibly lead to immunopathology. For instance, RIP3 and 
MLKL are overexpressed in inflamed ileum and colon tissues of patients with inflammatory 
bowel disease; necroptosis induces IL-1β, IL-8 and HMGB1 secretion in colonic HT-22 cells 
and contributes to inflammation [49, 50]. 
Accumulating evidence has implicated necroptosis in the pathogenesis of various diseases, 
including neurological disorders such as ischemic or hemorrhagic stroke, traumatic brain 
injury (TBI), spinal cord injury (SCI), Alzheimer’s, multiple sclerosis, amyotrophic lateral 
sclerosis (ALS) and other neurodegenerative diseases [51]. On one hand, necroptosis can be 
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the regulated necrosis mechanism of neurons; on the other hand, necroptotic microglia and 
oligodendrocytes may exacerbate pathogenic immune responses. Incubation with 1 ng/ml 
TNFα and 50 µM zVAD-FMK for 4 h in vitro can efficiently induce necroptotic cell death in 
the hippocampal neuron cell line HT-22, suggesting that molecular machinery of necroptosis 
exists in neurons [52]. Necroptosis also contributes to motor neuron death in experimental 
models of ALS. In lower spinal cord from human ALS pathological samples, Ito et al. 
observed upregulation and phosphorylation of necroptosis regulators RIPK1, RIPK3 and 
MLKL, especially in the region that displays axonal pathology [53]. Additionally, 
upregulation of these necroptotic markers RIP1, RIP3 and MLKL were observed in the spinal 
cords in both mSOD1 (misfolded superoxide dismutase 1) and Optineurin knockout mouse 
models of ALS [53]. Furthermore, the protective effects of RIP1 inhibitor necrostatin-1 and 
MLKL antagonist necrosulfonamide (NSA) for motor neurons in vitro and in vivo confirm the 
involvement of necroptosis in ALS pathogenesis [54]. Increased expression levels of RIP3, 
MLKL and HMGB1 were also present in spinal cords following traumatic injury; necrostatin-
1 inhibits motor neuron death in SCI without affecting apoptosis [55, 56]. Taken together, 
necroptotic cell death can be involved in motor neuron degeneration, which is exemplified in 
the case of ALS and SCI.  
Virus-induced necroptosis has also been described following infections with both DNA 
viruses (including MHV68, HSV and vaccinia virus) and RNA viruses (including HIV, IAV, 
JEV, Sendai virus and reovirus) [57-62].  DNA viruses, for example, vaccinia virus may 
sensitize host cells to TNFα-dependent necroptotic death by encoding a caspase-8 inhibitor 
B13R [60]. Otherwise, MCMV and MHV68 infection can induce necroptosis by activating 
the DNA sensors DAI and STING pathways respectively; HSV-1 and HSV-2, on the other 
hand, encode viral RHIM-containing proteins ICP6 and ICP-10, which directly engage the 
RIP1/ RIP3 necrosome [61]. The mechanisms of RNA virus activated necroptosis are less 
studied: IAV activates necroptosis via DAI and Sendai virus triggers necroptosis via RIG-I 
[57, 62].  Besides, the production of IFN-β and de novo synthesis of viral RNA are both 
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required for activation of necroptosis signaling cascade during reovirus replication in L929 
cells [59]. 
It has been shown that necroptosis can be protective in vivo by restricting virus propagation 
and coordinating immune responses, and viruses such as HSV1 and MCMV encode viral 
inhibitors of necroptosis to block this antiviral cell death [47, 61]. Interestingly, mutant 
human coronavirus strain OC43 (HCoV-OC43), which has enhanced neurovirulence, 
astrogliosis and mortality in mice, induces increased mRNA transcription of RIP1 and RIP3 
compared to the wild-type virus, without affecting their protein levels. Besides, RIP1 
knockdown and the MLKL antagonist NSA prevents HCoV-OC43- induced cell death of 
human neuroblastoma cells and primary mouse CNS cultures [63]. Another encephalitic virus, 
JEV, is also shown to induce MLKL upregulation in neurons both in vitro and in vivo. 
Deletion of MLKL delays the onset of JE and alleviates the symptoms, at least partly due to 
reduced levels of inflammatory cytokines [58]. These lead to the hypothesis that HCoV-
OC43- or JEV- induced necroptosis contributes to neuroinflammation and CNS damage.  
Here we sought to understand whether regulated necrosis contributes to the pathogenic 
inflammation and motor neuron degeneration during SINV infection. Considering the 
involvement in neurologic disorders and the best-characterized molecular mechanism, we 
would start by looking into evidence for the necroptosis pathway. Earlier studies 
demonstrated that TNFα, the prototype necroptosis inducer, is upregulated in the brain and 
spinal cords of SINV-infected mice [64]. Besides, TNFα and TNFR deficient mice exhibit 
more resistance to NSV-induced brainstem and cervical motor neuron cell death as well as 
decreased mortality [65, 66]. Therefore, I will evaluate the presence of necroptotic cell death 
in SINV- infected NSC-34 cell line and in mouse spinal cord, using RIP3 upregulation as an 
indicator. 
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Materials and Methods 
NSC34 cells culture and differentiation 
The murine NSC34 cell line was a hybrid of N18TB2 neuroblastoma cells and embryonic 
mouse spinal cord motor neurons and was kindly provided by Dr. Neil Cashman (University 
of Toronto, Canada). Cells were maintained at 37°C in 5% CO2 in growth medium that 
contains Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% heat 
inactivated fetal bovine serum (FBS), 1% penicillin/ streptomycin (Gibco), 1% L-Glutamine 
(Gibco) and were subcultured every 3 days. 
For differentiation, NSC34 cells were plated at a density of 5 x 104 cells/ cm2 in 6 well plates 
with or without matrigel (Becton-Dickinson Biosciences) coating. One day after plating, 
growth medium was exchanged for 1:1 DMEM/ Ham's F12 (Gibco) with 1% FBS, 1% 
penicillin/ streptomycin, 1% L-Glutamine, 1% modified Eagle's medium nonessential amino 
acids (MEM-NEAA) and 10 mM all-trans retinoic acid (Sigma-Aldrich). Cells were 
differentiated for up to four days and differentiation medium was changed every 2 days. 
In vitro viral infection 
Cell viability was determined using trypan blue exclusion. TE virus stocks of 2.5 x 109 plaque 
forming unit (pfu)/ ml were titered on BHK cells and were diluted in DMEM with 1% FBS to 
the designated multiplicity of infection (MOI). Undifferentiated cells seeded for 24 hours or 
differentiated cells were incubated with the virus for 1 h in appropriate conditions and the 
plates were rocked every 15 min. After washing with PBS, the virus containing media was 
then replaced with fresh DMEM with 1% FBS.  
Plaque assay 
Supernatant fluids were collected from culture media 0, 8, 12, 24, 48 and 72 hours post 
infection (hpi) and frozen at -80°C. BHK cells were plated one day before the experiment. 
Cell monolayers were washed with PBS and were then infected with 200 µl of serially diluted 
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supernatant fluids. After 1 h incubation and regular rocking, cells were overlaid with 
bacterose agar with 50% MEM and 8% FBS. After agar solidified at room temperature, BHK 
cells were incubated at 37°C for approximately 2 days, and were stained with neutral red for 
counting the number of plaques. 
In vivo viral infection and tissue collection 
Four to six week old wild-type C57BL/6 mice were anaesthetized with isoflurane and 
intracranially (i.c.) inoculated with 1000 pfu of either TE or NSV virus suspended in 20 µl of 
PBS by Dr. Victoria Baxter. Similarly, IRF3-/- and IRF7-/- mice were i.c. infected with 1000 
pfu of TE virus by Elizabeth Troisi.  
For brain and spinal cord collection, mice were deeply anaesthetized and perfused with 15 ml 
ice-cold PBS. Small intestine was also harvested from uninfected C57BL/6 mice, used as 
positive control for western blot analysis of RIP3. All tissue samples were snap-frozen in 
liquid nitrogen, stored at - 80°C and supplied to me by either Dr. Baxter or Elizabeth Troisi.  
All mouse experiments were performed in accordance with protocols approved by the Johns 
Hopkins University Animal Care and Use Committee. 
Total RNA extraction 
For RNA extraction from brain and spinal cord, tissue samples were homogenized in TRIzol 
reagent (Invitrogen) and were centrifuged at 12,000 ×g for 10 min at 4°C. The supernatant 
fluid was mixed with chloroform thoroughly and incubated at room temperature for 3 min. 
The upper aqueous layer was then separated by centrifugation at 12,000 ×g for 15 min and 
collected in new tubes. Following isopropanol precipitation, RNA pellets were washed twice 
with 75% ethanol and air dried for 10 min. After resuspension in DNase/ RNase-free DEPC 




Semi-quantitative RT-PCR analysis of mRNA and microRNA  
For mRNA expression analysis, 4 µg of RNA were reverse transcribed into cDNA utilizing 
the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems) and an Applied 
Biosystems 2720 thermal cycler. Real-time PCR was then performed using EagleTaq 
Universal Master Mix w/ ROX (Roche, 07249926190) and specific PrimeTime predesigned 
primer and probe sets obtained from Integrated DNA Technologies (Table 1). The PCR 
conditions were 50°C for 2 min, 95°C for 10 min, and 50 cycles of 95°C for 15 s, and 60°C 
for 1 min. Transcript levels of target genes were normalized to the endogenous levels of 
GAPDH mRNA and fold changes relative to the uninfected controls were calculated using 
2−ΔΔCt method.  
Gene Assay ID Reference Seq no. 
Mouse Tlr3 Mm.PT.58.8085919 NM_126166(1) 
Mouse Tlr7 Mm.PT.58.10526075 NM_133211(1) 
Mouse Tlr8 Mm.PT.58.16021150 NM_133212(1) 
Mouse Tlr9 Mm.PT.58.5114450 NM_031178(1) 
Mouse Myd88 Mm.PT.58.33389595 NM_010851(1) 
Mouse Sarm1 Mm.PT.58.41336232 NM_001168521(2) 
Mouse Rip3 Mm.PT.58.33227794 NM_001164108(3) 
Mouse Mlkl Mm.PT.58.16870825 NM_029005(1) 
Rodent Gapdh 
Rodent GAPDH forward primer  
/ Rodent GAPDH reverse primer  
/ Rodent GAPDH Probe (VIC) (Applied Biosystems) 
Table 1: Primers used for RT-PCR analysis 
For miR-21 and miR-146 expression analysis, 10 ng of total RNA were reverse transcribed 
into cDNA using TaqMan Advanced miRNA cDNA Synthesis Kit (Cat. no. A28007), 
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according to the manufacturer's protocol. Quantification of miRNAs was performed using 
TaqMan Advanced miRNA Assays (Applied biosystems, Cat. no. A25576) listed in Table 2 
and TaqMan Fast Advanced Master Mix (Cat. no. 4444556). Each sample was analyzed in 
duplicate and normalized to the expression levels of let-7c.  




Table 2: Taqman MicroRNA assays used for miRNA RT-PCR analysis 
Western blot analysis 
NSC34 cells and mouse tissue were homogenized by sonication in RIPA buffer (50 mM Tris, 
150 mM NaCl, 1% NP-40, 0.5% Sodiumdeoxycholate, 1 mM EDTA and 0.1% SDS) 
supplemented with protease inhibitor cocktail (Sigma) and phosphatase inhibitor (Sigma), and 
incubated on ice for 30 min. Supernatant fluid was harvested after centrifugation at 12,000 
rpm for 15 min at 4°C and stored at - 80°C. The concentrations of total proteins were 
determined using DC Protein Assay (Bio-rad). Samples were boiled in 6x cracking buffer (0.5 
M Tris, 10% sodium dodecyl sulfate, 30% glycerol, 6% β-mercaptoethanol and 0.12% 
bromophenol blue) for 5 min. For RIP3 expression level analysis, 150 µg protein from brain 
and spinal cord homogenates, 40 µg protein from small intestine samples or 20 µg of protein 
from NSC34 cell lysate per well was resolved using 4-20% Tris-Glycine Universal gels 
(NuSep Cat. No. NG11-420). Proteins were transferred to nitrocellulose membrane (Bio-rad) 
in 10% methanol transfer buffer, and blocked with 5% non-fat skim milk in Tris buffered 
saline with 0.1% Tween 20 (TBS-T) for 1 h at room temperature. Membranes were then 
incubated in anti-RIP3 antibody (1: 1000, Cell signaling D4G2A or Abcam ab56164) or anti-
β-actin (1: 10000, Cell signaling) in TSB-T with 5% BSA at 4°C overnight. After washing 3 
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times in TBS-T for 5 min, membranes were then incubated with either goat anti-rabbit (1: 
2,000) or anti-mouse (1: 10,000) horseradish peroxidase (HRP)-conjugated secondary 
antibody for 1 h at room temperature. Following 5 washes with TBS-T buffer, 
chemiluminascence signals were developed using the ECL Western blotting detection reagent 
(GE Healthcare Life Sciences). 
Immunohistochemistry staining 
Paraffin-embedded, paraformaldehyde-fixed sections were heated at 60°C for 10 min and 
then rehydrated by successive immersion in xylene, 100% ethanol, 95% ethanol, 70% ethanol, 
and running tap water, respectively. Sections were boiled in 10 mM Sodium citrate buffer (pH 
= 6) for 8 min for heat-induced antigen retrieval by a microwave, cooled for 20 min, and 
washed three times in TBS with 0.025% Triton-X. Endogenous peroxidase activity was 
quenched using freshly prepared 3% hydrogen peroxide in methanol for 10 min. Tissues were 
then blocked in 1x PBS with 0.04% Triton-x and 10% Normal Goat Serum (NGS) for 30 min. 
After overnight incubation with anti-RIP3 antibodies (1: 200 in 1x PBS with 0.04% Triton-x 
and 5% NGS, Abcam ab56164) at 4°C in a humidified chamber, slides were washed with 
TBS/ Triton-x wash buffer for 3 times and stained with biotinylated anti-rabbit IgG antibody 
(1: 300 dilution, Vector Laboratories, Cat. no. BA-1000) for 40 min at room temperature. 
Sections were then incubated in VECTASTAIN Elite ABC reagents (Vector Laboratories, 
Cat. no. PK-6100) for 40 min and developed in DAB solution (Vector Laboratories, Cat. no. 
SK-4100) for 8 min. Finally, slides were counterstained with 1: 10 hematoxylin for 1 min, 
dehydrated, and mounted with Permount. 
Statistical analysis 
Two-way ANOVA with Bonferroni post-tests was used to compare the difference among 
different groups during the course of infection. Data were presented as mean ± standard error. 
The differences were considered statistically significant when p-value < 0.05. All statistical 
analysis was performed using GraphPad Prism 5.  
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Results 
Endosomal TLRs and downstream adaptors are upregulated by SINV in wild-type B6 mice 
The NSV strain is known to cause lethal immune-mediated encephalomyelitis in wild-type 
adult C57BL/6 (B6) mice, while TE infection causes only mild disease. As endosomal TLRs 
are capable of recognizing viral nucleic acids, and are implicated in immune responses of 
several neurotropic viruses, we would like to know whether these TLRs are associated with 
the severity of SINV-induced disease. Considering the divergent cell death pathways 
activated by SINV in the brain and spinal cords, we would also examine TLR expression at 
both regions. Therefore, mRNA expression of endosomal TLRs in the brain and spinal cords 
following TE or NSV infection were compared by semi-quantitative RT-PCR. The mRNA 
levels of TLR3, TLR7, TLR8 and TLR9 were all significantly increased during the seven-day 
course of infection, by both TE and NSV strains of SINV (Figure 5A). Similar transcription 
profiles were observed in the brain and spinal cord. TLR3 expression peaked during 3 to 5 dpi 
and was increased by about 10-fold and 5-fold by the NSV and TE strains respectively (p < 
0.05) in the CNS. TLR7, TLR8 and TLR9 mRNA levels, however, reached maximum at later 
time points. NSV infection upregulated TLR7 transcription by approximately 15-fold at 7 dpi, 
while TE only induced TLR7 mRNA level by 5-fold (p < 0.05). Although no significant 
difference was observed in TLR8 and TLR9 transcript levels induced by NSV and TE, these 
results indicated the general trends of higher upregulation of endosomal TLR genes by the 







Figure 5. Upregulation of endosomal TLRs and Myd88 during SINV infection in the 
brain and spinal cord of wild-type mice. Wild-type adult C57BL/6 mice were 
intracerebrally infected with either TE or NSV strain of SINV, and RNA was extracted from 
the brain and spinal cord harvested at 0, 1, 3, 5 and 7 dpi. Relative gene expression of 
endosomal TLR3, 7, 8 and 9 (A) and TIR family adaptors MyD88 and SARM1 (B) were 
analyzed by semi-quantitative RT-PCR assay. The data were normalized to GAPDH mRNA 
levels and were expressed as the relative fold change over normalized mRNA from 
uninfected mice (mean ± SE). Five to six animals were included per time point for each virus 
strain. Two-way ANOVA with Bonferroni posttest was conducted for statistical analysis. (* p 
< 0.05, ** p < 0.01, *** p <0.001). 
  
Recognition of viral RNA by TLRs results in activation of TIR domain-containing adaptors 
MyD88 and TRIF that induce downstream signaling pathways. The fifth TIR adaptor, 
SARM1 is recently demonstrated to play important roles in regulating neuronal morphology 
and functions. TLR7/9 or MAVS-mediated SARM1 activation is also implicated in 
neurodegeneration. Expression levels of SARM1 and the classical TIR adaptor MyD88 were 
evaluated following infection with either NSV or TE strain of SINV. In the brain and spinal 
cord, MyD88 was upregulated by more than 6 fold and 3 fold after 3 dpi by NSV and TE as 
B	
	 24	
compared to the control (Figure 5B). However, despite a mild decrease at early time points 
following NSV infection, SARM1 mRNA levels remained constant in the CNS. 
These results showed that endosomal TLRs and MyD88 rather than SARM1 were 
transcriptionally upregulated in response to SINV infection. However, whether these genes 
were also induced at protein levels was unknown. Besides, the neurovirulent NSV strain 
induced higher levels of TLR3, TLR7 and MyD88 transcripts in the CNS than the TE strain 
of SINV. These results lead to the hypothesis that TLR-MyD88 signaling correlates with the 
severity of SINV-induced encephalomyelitis. 
Endosomal TLRs and MyD88 are upregulated by SINV in IRF7−/− and IRF3−/− mice 
IRF3−/− and IRF7−/− mice developed more severe disease after infection with the TE strain of 
SINV than wild type mice. IRF7−/− mice developed hindlimb paralysis and showed increased 
mortality compared to wild type or IRF3 knockout mice. To evaluate whether mRNA levels 
of endosomal TLRs and the downstream adaptor proteins were also upregulated in IRF3−/− 
and IRF7−/− mice, wild type and IRF knockout mice were infected with TE and brain and 
spinal cord samples were harvested at 0, 1, 3, 5, 7 dpi.  RT-PCR analysis showed that TE 
infection significantly induced endosomal TLRs and MyD88 transcription after 3 dpi (Figure 
6). Greater upregulation of the TLR and MyD88 transcripts in the brain and spinal cord was 
observed in IRF deficient mice compared to the wild type mice, particularly from 5 to 7 dpi. 
Moreover, relative changes in TLR7 mRNA levels were significantly higher in the brains of 
IRF7-/- mice compared to IRF3-/- mice at 5 and 7 dpi (p < 0.001). In the spinal cord, TLR7 
mRNA was increased by an average of 14 fold in IRF7-/- and 10 fold in IRF3-/- mice (Figure 
6A). As observed in TE or NSV infected wild type mice, SARM1 mRNA expression was also 
not prominently affected in IRF7−/− and IRF3−/− mice following TE inoculation (Figure 6B). 






 Figure 6. Upregulation of endosomal TLRs and Myd88 during SINV infection in the 
brain and spinal cord of wild-type and IRF knockout mice. Wild type, IRF3-/- and IRF7-/- 
adult C57BL/6 mice were intracerebrally infected with the TE strain of SINV, and RNA was 
extracted from the brain and spinal cord harvested at 0, 1, 3, 5 and 7 dpi. Relative gene 
expression of endosomal TLR3, 7, 8 and 9 (A) and TIR family adaptors MyD88 and SARM1 
(B) were analyzed by semi-quantitative RT-PCR assay. The data were normalized to GAPDH 
mRNA levels and were expressed as the relative fold change over normalized mRNA from 
uninfected mice (mean ± SE). Five to six animals were included per time point for each 
mouse strain. Two-way ANOVA was conducted for statistical analysis. (* p < 0.05, ** p < 
0.01, *** p < 0.001 represented significant difference between IRF7-/- and wild type mice; # p 
< 0.05, ## p < 0.01, ### p < 0.001 represented difference between IRF3-/- and wild type mice; + 




SINV infection induces miRNA-21 and miR-146 expression in the CNS 
Dysregulation of miRNAs was examined using a limited microRNA microarray analysis 
previously. Two miRNAs, miRNA-21a-5p and miRNA-146a-5p, were significantly induced 
in the brains of mice infected with TE at 5 dpi, according to the criterion of more than 2 fold 
upregulation. We sought to validate the expression changes of these two miRNAs by 
microRNA RT-PCR assay. Additionally, we would examine the dynamics of miR-21a and 
miR-146a expression following infection with both NSV and TE strains of SINV in the CNS. 
Another miRNA, let-7c-5p, was chosen as the endogenous control because of its stability and 
low variability on the miRNA microarrays. The relatively constant expression of let-7c-5p in 
the brain and spinal cord during the 7-day period of infection was confirmed by miRNA RT-
PCR (Figure 7A); consequently let-7c was used for normalizing the levels of other miRNAs. 
In agreement with the microarray data, RT-PCR analysis revealed that miR-21a and miR-
146a were significantly induced by SINV infection at 5 dpi (Figure 7B). Both miRNAs were 
upregulated gradually from 3 dpi in the brain and spinal cord, when compared with 
uninfected animals. Additionally, the neurovirulent strain NSV induced higher levels of miR-
21a-5p than the less virulent TE strain; with around 10-fold increase in the brains of NSV 
infected mice and 5-fold increase in TE infected mice at 7 dpi (p value < 0.001). SINV-
induced overexpression of miR-146a-5p was also observed in the CNS but with lower levels 
of change. Besides, there is little or no difference in miR-146a expression observed in NSV 
and TE infected brain and spinal cord (Figure 7B).  
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Figure 7. Induction of miR-21a and miR-146a by SINV infection in the CNS of wild type 
mice. Total RNA was extracted from the brain and spinal cord of wild-type adult C57BL/6 
mice infected with NSV and TE for 0, 1, 3, 5 and 7 days. MicroRNA RT-PCR analysis 
confirmed the relative stable Ct values of let-7c in the CNS (A). Levels of miR-21a and miR-
146a were normalized to endogenous let-7c levels, and relative expression changes were 
determined using the 2–ΔΔCt formula (B). Experiments were run in duplicate and five to six 
samples were included per time point per group. Two-way ANOVA was used for statistical 
analysis (*** p < 0.001). 
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Because miR-146a expression was not differentially regulated in response to TE and NSV 
infection, we next examined only the levels of miRNA-21a expression in IRF3-/- and IRF7-/- 
mice. Consistent with the results in wild type mice, miRNA RT-PCR revealed that miR-21a 
was also significantly induced by TE infection in IRF knockout mice compared with 
uninfected controls (Figure 8). Additionally, higher levels of miR-21a were present in both 
IRF3-/- and IRF7-/- mice, with approximately 8-fold increase in knockout mice and 4-fold 
increase in wild type mice at 7 dpi (p value < 0.001, Figure 8). These results indicated that 




Figure 8. miR-21a upregulation by SINV in the brain of wild-type and IRF knockout 
mice. Total RNA was extracted from the brain wild type, IRF3-/- and IRF7-/- C57BL/6 mice 
infected with TE strain of SINV. MicroRNA RT-PCR analysis was performed to determine 
the relative expression levels of miR-21a after 0, 1, 3, 5 and 7 dpi. Data were normalized to 
endogenous let-7c levels, and relative expression changes were calculated using the 2–ΔΔCt 
formula. Experiments were run in duplicate and three samples were included per time point 
per group. Two-way ANOVA with Bonferroni post-hoc test was used for statistical analysis 
(*** p < 0.001 indicated significant difference between IRF7-/- and wild type mice; ### p < 





NSC34 cells were not fully differentiated 
Owing to their motor neuron origin, NSC34 cell line is commonly employed as an in vitro 
system for studying motor neuron diseases such as amyotrophic lateral sclerosis (ALS) and 
traumic spinal cord injury (SCI). As SINV infection induces differential cell death 
mechanisms in neurons from different sources, we investigated the mechanisms of SINV-
induced motor neuron degeneration using the NSC34 cell line. To better mimic motor 
neurons in adult mice, NSC34 cells were differentiated by serum depletion and addition of 10 
µM all-trans retinoic acid (atRA). This is higher than the concentration of 1 µM previously 
reported in the literature, possibly due to variation of origin and repeated passage of the cell 
line. NSC34 cells grown in atRA-containing differentiation medium for more than 2 days 
displayed inhibited cell proliferation and significant neurite outgrowth (Figure 9A). The 
phenotype of differentiated motor neurons, however, started to disappear after one week, 
suggesting the incomplete differentiation of NSC34 cells under this condition. Culturing cells 
on matrigel-coated plates accelerated cell differentiation, but was also unable to help maintain 
the differentiated state.  
Resistance to SINV infection increased with NSC34 maturation (Figure 9B). However, 
consistent with previous results, these partially differentiated NSC34 cells remained 
permissive to SINV. Unlike differentiated AP7 (a rat odora olfactory neuronal cell line) and 
CSM14.1 (a rat mesencephalic progenitor cell line) that are able to restrict virus replication, 4 
day differentiated NSC34 cells replicated TE strain of SINV to comparable titers as 
undifferentiated NSC34 cells by 48 hpi (Figure 9B) [15]. Therefore, whether differentiated 
NSC34 cells represents a suitable in vitro model for studying SINV-induced motor neuron 








Figure 9. Morphology and SINV growth curves in cycling and differentiated NSC-34 
cells. Undifferentiated cells had short or no neurites, while extensive neuron-like processes 
were observed in NSC34 cells cultured in differentiation medium with 1% FBS and 10 µM 
atRA. Representative images of undifferentiated and 3 day differentiated cells were captured 
using phase contrast microscope (20x magnification) (A). Cycling, 2 day- and 4 day-
differentiated NSC34 cells were infected with the TE strain of SINV at an MOI of 1 or 5. 
Viral titers in supernatant fluids of TE infected NSC34 cells were determined using plaque 
assay on BHK cells over 72 hours post infection (B). Results were expressed as the average 
log10 pfu/ ml ± standard error of three different wells.  
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RIP3 expression is undetectable in NSC34 cells  
RIP3 is a crucial regulator of necroptotic cell death. Elevated RIP3 expression is an indicative 
marker for this regulated necrosis pathway and has been observed in damaged tissue in 
various disease models such as alcoholic liver disease, inflammatory bowel disease, ischemic 
brain/ spinal cord injury and ALS. To assess the involvement of necroptosis in SINV-induced 
neuronal cell death, we investigated the expression of RIP3 protein in NSC34 cells using 
western blotting. The anti-RIP3 antibody detected a band of about 57 kDa, demonstrated in 
the small intestine samples that served as positive controls. We were unable to observe 
endogenous RIP3 protein in either undifferentiated or 4 day-differentiated NSC34 cells 
(Figure 10). In addition, TE strain of SINV infection at an MOI of 1 in cycling and 




Figure 10. Western blot analysis of RIP3 in NSC34 cells infected with SINV. 
Undifferentiated and 4 day-differentiated NSC34 cells were infected with TE strain of SINV 
at an MOI of 1. Mock or TE infected NSC34 cells were collected at 48 hpi. Protein lysates 
were resolved by SDS-PAGE and analyzed by western blotting using a rabbit monoclonal 
anti-RIP3 antibody (Cell signaling, Cat. no. 95702S). No bands were detected within the 




SINV infection does not induce RIP3 overexpression in the spinal cord 
Necroptosis drives motor neuron degeneration in ALS and spinal cord injury. To evaluate 
whether NSV-induced motor neuron necrosis is necroptotic, we first investigated the changes 
in RIP3 and MLKL mRNA levels in the brain and spinal cord following SINV infection. 
Semi-quantitative RT-PCR showed that RIP3 and MLKL mRNA levels were upregulated by 
the TE and NSV strains of SINV virus in both brain and spinal cord over time with relatively 
higher expression levels induced by the NSV strain (Figure 11). RIP3 mRNA expression was 
significantly higher at 7 dpi in the brain (p < 0.001) and at 5 dpi in the spinal cord (p < 0.01) 
in NSV infected mice compared to the TE group. The average MLKL transcription levels 
were also higher in the brain and spinal cord of NSV infected mice compared with TE 
infected ones, although no significant differences were observed. Besides, greater relative 
change in RIP3 and MLKL expression occurred in the brain rather than in the spinal cord. For 
instance, NSV infection increased RIP3 mRNA by approximately 33-fold in the brain and 23-
fold in the spinal cord at 7 dpi; MLKL mRNA levels peaked at 5 dpi following NSV infection, 
with roughly 129-fold increase in the brain and 61-fold in the spinal cord. 
We then compared RIP3 protein levels in the spinal cords of mice infected with TE and NSV. 
We intracerebrally infected C57BL/6 mice with either TE or NSV strain of SINV, and 
collected spinal cord samples, at 5 and 7 dpi when motor neuron necrosis was likely to occur. 
Western blot analysis showed that RIP3 was expressed at very low levels in the CNS 
compared to other tissues [67]. As in Figure 12A, the 57 kDa bands were faint when 150 µg 
of protein from spinal cords was loaded. By contrast, darker bands were detected when only 
40 µg protein from small intestine homogenates were resolved. Expression levels of RIP3 
protein were highly variable in each group, and no significant increase in RIP3 expression 
was detected in the spinal cords of TE or NSV infected mice compared to the uninfected 
group (Figure 12B). Therefore, western blotting could not provide any conclusive evidence to 







Figure 11. RIP3 and MLKL mRNAs are upregulated during SINV infection in the 
brain and spinal cord of wild-type mice. Wild-type adult C57BL/6 mice were 
intracerebrally infected with either TE or NSV strain of SINV, and RNA was extracted from 
the brain and spinal cord harvested at 0, 1, 3, 5 and 7 dpi. Relative gene expression of RIP3 
and MLKL mRNAs were analyzed by semi-quantitative RT-PCR assay. The data were 
normalized to endogenous GAPDH mRNA levels and were expressed as the relative fold 
change over normalized mRNA from uninfected mice (mean ± SE). Five to six animals 
were included per time point for each virus strain. Two-way ANOVA with Bonferroni 










Figure 12. Western blot analysis of RIP3 expression in the spinal cord following SINV 
infection. Wild-type C57BL/6 mice were intracerebrally infected with either TE or NSV 
strain of SINV at four to six weeks of age. Spinal cords were harvested at 0 (mock), 5 and 7 
dpi and homogenized in RIPA buffer. Protein lysates were resolved by SDS-PAGE and 
analyzed by western blotting using a rabbit monoclonal anti-RIP3 antibody (Cell signaling, 
Cat. no. 95702S) (A). To confirm the specificity of the anti-RIP3 antibody, extracts of small 
intestine from uninfected C57BL/6 mice was loaded as a positive control. The intensities of 
protein bands were quantified using the NIH ImageJ software (http://rsbweb.nih.gov/ij/) and 
the loading differences were normalized with reference to the β-actin bands. Densitometric 
analysis from three independent samples showed no statistical difference between RIP3 
expression levels in TE or NSV infected mice spinal cords and those in uninfected controls 





Next we examined RIP3 protein expression in the spinal cord using immunohistochemistry 
staining. Since the slides from the NSV infected wild type mice were presently not available, 
I evaluated RIP3 protein levels in the spinal cord of wild type, IRF3-/- and IRF7-/- adult 
C57BL/6 mice instead. As TE infection also induces caspase-3 independent neuronal death in 
the spinal cord and causes hindlimb paralysis in IRF7-/- mice like the NSV strain did in wild 
type mice, we hypothesized that motor neuron degeneration in these two cases involves the 
same cell death mechanism. Wild type, IRF3-/- and IRF7-/- adult C57BL/6 mice were 
intracerebrally infected with the TE strain of SINV, and the spinal cord samples were 
obtained at 5 and 7 dpi. Immunohistochemical analysis was performed using anti-RIP3 
antibody (Abcam ab56164), and no RIP3 positive cell was detected in the spinal cord sections 
of all three strains of mice at 5 or 7 dpi. Representative figures of 7 dpi sections were shown 
in Figure 13 A-C. To confirm the immunoreactivity of this antibody, the same procedures 
were performed with small intestine and stomach sections obtained from wild type, 
uninfected mice. As in Figure 13D, RIP3 expression was detected in gastric mucosa lamina, 
which is consistent with the literature [67]. These suggested that infection with the TE strain 
of SINV did not induce RIP3 expression detectable by immunohistochemistry in the spinal 
cord of IRF-/- mice. 
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Figure 13. Immunohistochemistry analysis of RIP3 expression in the spinal cord 
following SINV infection. Wild type, IRF3-/- and IRF7-/- adult C57BL/6 mice were 
intracerebrally infected with the TE strain of SINV, and the spinal cord samples were 
obtained harvested at 7 dpi. Representative pictures of immunostaining for RIP3 in the spinal 
cord of wild type (A), IRF3-/- (B) and IRF7-/- (C) are shown. A photo of RIP3 staining in the 
stomach serves as the positive control (D). The arrow indicates RIP3-positive cell. Original 






TLR signaling and SINV infection 
The adaptive immune response plays critical roles in the pathogenesis of SINV-induced 
encephalomyelitis, yet the roles of innate immune pathways in regulating these processes 
have not been clarified. Endosomal TLRs are known to detect viral nucleic acids or 
replication complexes, and thus are considered central to immune defense against viral 
infections. Recent studies also showed that endosomal TLR activation in neurons can induce 
neuronal apoptosis or necroptosis, in an MyD88-dependent or SARM1-dependent manner. 
The fifth member of TIR family adaptor protein, SARM1, is abundantly expressed in neurons 
and has been implicated in neuronal cell death triggered by oxygen glucose deprivation, 
mitochondria dysfunction and viral infection. Using RT-PCR, we observed that all four 
endosomal TLRs selected for analysis and MyD88 were upregulated in the brain and spinal 
cord following SINV infection at a transcriptional level. In addition, the level of induction 
seemed to correlate with the severity of symptoms. The fatal NSV strain of SINV stimulated 
higher levels of TLR3, TLR7 and MyD88 mRNAs than the TE strain in the CNS. TLR7 
mRNA levels were also significantly higher in TE infected IRF7-/- mice than in IRF3-/- and 
wild type mice, which were relatively less susceptible to SINV infection.  
Although we did not investigate the expression of endosomal TLRs and associated adaptors at 
the protein levels, these findings provided preliminary data suggesting that endosomally 
located TLRs, especially TLR7, might be involved in SINV pathogenesis. However, one 
study has shown that survival from NSV encephalitis in MyD88 and TLR3 knockout mice 
was not significantly different from wild type mice [68]. This conflicts with our hypothesis 
that TLR-dependent signaling contributes to SINV disease outcome. Nevertheless, TLR3 and 
MyD88 mediated pathways may have redundant functions. Another possibility is SINV may 
activate endosomal TLR signaling that requires a noncanonical adaptor protein, for instance 
SARM1, rather than the classical MyD88 protein.  
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SARM1 mRNA expression was not affected by SINV infection in the brain and spinal cord. 
Nonetheless, we cannot rule out the possibility that SARM1 is regulated at the 
posttranscriptional level. For example, the TLR4 ligand LPS was previously reported to 
induce a rapid increase in SARM1 protein without affecting mRNA expression. Intracellular 
localization and dimerization are also important determinants for the functions of this adaptor 
protein. For instance, Mukherjee et al. demonstrated SARM1 trafficking and accumulation in 
mitochondria during TLR7/ 9 stimulation-induced apoptosis in primary cortical neurons [24]. 
However, SARM1 translocation to the nucleus was reported to inhibit TNFα induced 
apoptosis of HEK293 cells [69]. Besides, SARM1 dimerization through TIR domain 
interaction in response to neuronal injury triggers rapid consumption of NAD+ and decline in 
ATP level which leads to neuronal cell death or local axonal degeneration [70]. Further 
studies will be necessary to determine the roles of endosomal TLR- SARM1 signaling during 
SINV pathogenesis [30]. 
MiRNAs are small non-coding RNAs that typically bind to 3’ untranslated regions of mRNA 
and thus mediate posttranscriptional gene regulation. Recent studies demonstrate that 
miRNAs are capable of regulating virus-host interactions. Several DNA viruses and 
retroviruses, such as herpesviruses, encode viral miRNAs that can regulate both viral and host 
gene expression. Additionally, virus infections have been reported to alter the cellular miRNA 
expression profile. Viruses can hijack the cellular miRNA machinery to regulate their own 
replication, translation and pathogenesis, either by directly interacting with cellular miRNAs 
or by indirectly modulating host miRNA synthesis [71, 72].  
Here, we validated the results of previous microRNA microarray data from Dr. Yoshinari 
Ando that suggested upregulation of miR-21 and miR-146 in the brain and spinal cord during 
SINV infection by more than 2-fold. MicroRNA RT-PCR analysis showed that both miRNAs 
steadily accumulated during 7 dpi. Moreover, significantly higher levels of miR-21 were 
observed in NSV-infected wild type mice than those infected by the TE strain, and in the 
brains of TE-infected IRF deficient mice than those of wild type mice. However, the 
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mechanism, localization and functional relevance of this differential regulation are still not 
clear. MiR-21 is a well-studied “onco-miRNA” in tumor cells that regulate cell growth, 
migration, invasion and apoptosis through the suppression of its target genes such as BCL-2 
and Programmed cell death 4 (PDCD4). In neurons, miR-21 is reported to repress a CNS 
transcription factor, myocyte enhancer factor 2C (MEF2C), which is crucial for neuronal 
survival and functions [31]. Besides, miR-21 also modulates the production of type I IFNs 
and ISGs by targeting MyD88 and IRAK1 in the TLR signaling pathway. Several viruses 
including HCV, HIV and VSV upregulate miR-21, suppress antiviral immune response and 
promote virus replication [72]. Furthermore, miR-21 contains specific GU-rich motif that can 
directly bind and activate TLR7 signaling pathway. Yelamanchili et al. recently demonstrated 
that endogenous miR-21 was enriched in macrophage-derived EVs and induced a novel 
neurotoxic signaling pathway via neuronal TLR7 in SIV encephalitic brains [30]. Increased 
expression of EV miR-146 was also reported in mouse models of TBI and SIV encephalitis 
[73]. This miRNA can be activated by proinflammatory stimuli such as LPS and was 
considered to control inflammation in a negative feedback loop [74, 75].  MiR-146 in EVs 
was shown to downregulate IRAK1 and TRAF6 that were involved in TLR signaling 
cascades in recipient cells [74, 75]. 
Therefore, the mRNA and miRNA RT-PCR analysis here suggested that SINV infection 
activated transcriptional upregulation of endosomal TLRs, MyD88, miR-21 and-146 in the 
brain and spinal cord. The degree of upregulation of these genes, particularly TLR7 and miR-
21, appeared to correlate with the severity of encephalitic disease. At this point, it remains 
unclear whether SINV activates miR-21-TLR7 mediated neurotoxicity pathway like SIV.  
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Regulated necrosis and SINV infection 
Previous studies in our lab showed that the NSV strain of SINV activates divergent neuronal 
cell death pathways in the brain and spinal cord. Unlike NSV-induced apoptotic neurons in 
the brain of infected animals, damaged motor neurons display morphologic and biochemical 
characteristics of necrotic cells. Recent evidence indicates that necrosis can be a genetically 
programmed event and multiple forms of regulated necrosis have been described based on 
their unique molecular machinery. These include necroptosis, pyroptosis, parthanatos, 
oxytosis, ferroptosis and several other modes of cell death [44-46]. 
Necroptosis is the most extensively studied programmed necrosis pathway and can be 
activated by a variety of stimuli such as TNFα, Fas ligand, TLR3/ 4 agonists and DAI ligands 
[36]. Necroptosis is an inflammatory form of cell death and has been implicated in motor 
neuron degeneration in ALS and traumatic spinal cord injury. Earlier work demonstrates that 
increased secretion of TNFα, the classical necroptosis agonist, is induced by SINV infection 
both in vitro and in vivo [64, 66]. TNFα and TNFR deficiency are also reported to protect 
mice from fatal NSV diseases [65, 66]. Therefore, we proposed that TNFα or PRRs- triggered 
necroptosis might contribute to SINV pathogenesis in motor neurons. 
To investigate the hypothesis that necroptosis drives SINV-induced motor neuron loss, we 
first examined the regulation of RIP3 and MLKL mRNA in the brain and spinal cord in 
response to SINV infection. We showed that both RIP3 and MLKL were upregulated at a 
transcriptional level and the fatal NSV strain induced a greater change relative to the TE 
strain. However, more prominent upregulation was observed in the brain compared to the 
spinal cord for both genes, which can be conflicting with our original hypothesis that RIP3-
mediated necroptosis contributed to SINV-induced motor neuron degeneration.  
Then we assessed the expression of RIP3 protein in the spinal cord during SINV 
encephalomyelitis. However, we did not find any evidence of RIP3 upregulation in response 
to SINV infection using either western blotting or immunohistochemical staining. Western 
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blots showed that neither NSV nor TE strain of SINV promoted significantly increased levels 
of RIP3 in the spinal cord lysates relative to the uninfected controls, at 5 and 7 dpi when mice 
develop hindlimb paralysis. Owing to the low RIP3 expression levels and high background of 
the western blots, the aforementioned results were questionable. RIP3 protein was also 
undetectable by immunohistochemistry staining in the spinal cord of TE infected IRF7-/- mice, 
in which similar caspase-3 independent necrotic cell death was observed. Consistent with 
previous reports, both western blot and immunohistochemistry analysis showed that RIP3 
protein levels in the CNS were much lower than in other tissues, such as small intestine and 
stomach that served as positive controls [67]. Therefore, RIP3 protein was not induced to a 
detectable level in the spinal cord, though transcriptional upregulation was observed. 
Protein levels of RIP3 were also measured in SINV-infected NSC34 cells using western 
blotting. No RIP3 expression was observed above background levels in the homogenates of 
immature or 4-day differentiated NSC34 cells. In addition, we also failed to detect RIP3 
protein during the 48 hours post TE infection, though this might be attributable to the small 
amount of total protein resolved in the experiment. Additionally, RIP3 upregulation may 
occur after the 2-day period of infection included in the study; therefore, later time points 
should be examined in further studies. In view of the variation of cell line and incomplete 
differentiation, the use of differentiated NSC34 cells as in vitro model to study motor neuron 
disease is also problematic. Furthermore, majority of dead neurons in the lumbar spinal cord 
were not directly infected with NSV, suggesting that NSV activated a non-autonomous death 
pathway [78].  Consequently, co-culture motor neurons with glial cells may be more suitable 
for studying the cell death mechanism. 
In conclusion, we are unable to generate conclusive evidence for SINV-induced necroptosis 
in the spinal cord at the moment. Given the technical obstacles of RIP3 measurement, other 
biomarkers of necroptosis ought to be considered. Besides, RIP3 upregulation alone is also 
inconclusive due to the functions of RIP3 beyond necroptosis, including NFκB activation, 
inflammasome stimulation, kinase-independent apoptosis and cell death-independent 
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neuroinflammation [79, 80]. Hence, combined examination of these biomarkers, including but 
not limited to RIP1 upregulation/ phosphorylation, RIP1-RIP3/ RIP3-MLKL interactions, 
MLKL upregulation/ activation/ translocation, is required to evaluate the existence of 
necroptosis in SINV encephalomyelitis [76]. Pharmacologic blockade with synthetic 
inhibitors such as necrostatin-1, GSK-872 and NSA are also useful tools for studying 
necroptosis [76]. Considering the relatively higher levels of RIP3 and MLKL mRNAs in the 
brains, it will also be interesting to explore the roles of RIP3 pathways in this region in future 
studies. For instance, RIP3 activation induced neuroinflammation was recently demonstrated 
in the model of WNV encephalitis. 
Obviously, other forms of regulated necrosis can mediate SINV-induced motor neuron 
damage. For instance, oxytosis describes glutamate-induced oxidative cell death in neurons. 
In oxytosis (Figure 3), excessive extracellular glutamate can induce decreased cysteine import 
through the system XC− Cys/Glu antiporters and increased Ca2+ influx, which leads to GSH 
depletion, GPX4 inhibition, lipoxygenases overactivation and lipid peroxidation [44, 46]. 
Selective ablation of GPX4 in neurons results in rapid motor neuron death and development 
of paralysis, suggesting that motor neurons might be more vulnerable to oxytosis [81]. 
Several studies suggest that glutamate excitotoxicity plays a critical role in NSV-induced 
motor neuron degeneration [77, 82]. Besides, reactive oxygen species accumulation and lipid 
peroxidation were identified in lumbar spinal cord tissues derived from NSV-infected mice 
within 72 hpi [82]. These suggest that oxytosis can be another potential regulated necrosis 
pathway that contributes to NSV-induced motor neuron death. This neuronal death can be the 
combined outcome of regulated or accidental necrotic pathways. Further studies would 
potentially elucidate the mechanisms of SINV pathology in the spinal cords.  
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